Koninklijke Philips NV

Koninklijke Philips NV(PHG)の株式分析

$26.570

-0.149 (-0.56%)終値時点

Loading chart…
High
26.760
Open
26.720
VWAP
26.62
Vol
631.43K
Mkt Cap
24.07B
Low
26.540
Amount
16.81M
EV/EBITDA, TTM
8.26

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

AI analysis of Koninklijke Philips NV (PHG)

hold

Given the current price of $26.72 and a low RSI of 33.39 indicating oversold conditions, Philips NV may be a candidate for a long-term hold rather than a buy. However, the recent insider selling trend of 30126.47% raises concerns about confidence in the stock's near-term prospects. The forward P/E ratio of 14.60 suggests potential value, but the overall market sentiment remains cautious due to recent downgrades by analysts.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 26.57
安値
平均
高値

UBS

2026-08-03

目標株価

Neutral

Deutsche Bank

2026-07-30

目標株価

Hold

JPMorgan

2026-07-29

目標株価

Neutral

Citi

2026-07-01

目標株価

Neutral

Morgan Stanley

2026-06-23

目標株価

Equal Weight

バリュエーション指標

The current forward P/E ratio for Koninklijke Philips NV (PHG) is 14.56, compared to its 5-year average forward P/E of 15.68.

Forward P/E

Fair
5Y Average P/E
15.68
Current P/E
14.56
割高
21.54
割安
9.81

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.53
Current EV/EBITDA
8.26
割高
11.57
割安
7.49

Forward P/S

Fair
5Y Average P/S
1.16
Current P/S
1.40
割高
1.47
割安
0.86

Alphio AI Price Scenarios for PHG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PHG

$30.22

シナリオ価格

B

Base

Base · 50%PHG

$25.07

シナリオ価格

B

Bear

Bear · 25%PHG

$24.03

シナリオ価格

Whales holding PHG

L

Lingotto Investment Management LLP

+ HoldingPHG

+9.92%

3M Return

A

Artisan Partners Limited Partnership

+ HoldingPHG

+8.53%

3M Return

E

EdgePoint Investment Group Inc.

+ HoldingPHG

+8.25%

3M Return

M

Mondrian Investment Partners Limited

+ HoldingPHG

+6.87%

3M Return

B

Bestinver Gestión, S.A. SGIIC

+ HoldingPHG

+6.61%

3M Return

F

Fiduciary Management, Inc.

+ HoldingPHG

+4.93%

3M Return

PHG FAQ — answered by Alphio AI

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.

Given the current price of $26.72 and a low RSI of 33.39 indicating oversold conditions, Philips NV may be a candidate for a long-term hold rather than a buy. However, the recent insider selling trend of 30126.47% raises concerns about confidence in the stock's near-term prospects. The forward P/E ratio of 14.60 suggests potential value, but the overall market sentiment remains cautious due to recent downgrades by analysts.

1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める